본문 바로가기
KERD
논문KCI 등재

비소세포폐암종에서 CD44s, CD44v5 및 CD44v6 발현의 임상병리학적 의의

Clinicopathologic Significance of CD44s, CD44v5 and CD44v6 Expression in Non Small Cell Lung Carcinomas

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류병리학

초록

Abstract

Background : CD44 is a polymorphic family of transmembrane glycoproteins generated by alternative splicing of messenger RNA and is involved in the mechanism of tumor invasion and metastasis. Methods : The expression of selected CD44 molecules (CD44s, CD44v5, and CD44v6) was determined immunohistochemically in 84 cases of non small cell lung carcinomas (NSCLCs). The results were compared with PCNA index, microvessel density (MVD), and clinicopathological parameters including patient’s survival. Results : CD44s showed a positive reaction in 61.9% (52/84) of NSCLCs, CD44v5 in 73.8% (62/84), and CD44v6 in 39.3% (33/84). Squamous cell carcinomas (SCCs) displayed preferential expression of all CD44 molecules in comparison with adenocarcinomas (ACs) (p<0.001). As a whole, the expression of CD44 molecules was not correlated with clinical parameters (stage, TNM-T, and TNM-N), PCNA index, or MVD. For ACs only, however, CD44v5 expression was negatively correlated with PCNA index (p<0.05). Poor survival was correlated with CD44v5 expression in ACs and CD44v6 in SCCs (both, p<0.05). Conclusions : These findings suggest that CD44 molecule in NSCLC could be a distinctive phenotypic marker for SCC, and the possibility that CD44v5 and CD44v6 are in some way instrumental in conditioning the biologic behavior of NSCLC according to major histologic types.

참고문헌 (30)

  1. "Lung cancer in Korea", 34, pp.1~2 (2002)
  2. "Epidemiology of lung cancer in Korea", 34, pp.3~7 (2002)
  3. "Risk of recurrence in patients withsurgically resected stage I non-small cell lung carcinoma", 123, pp.1858~1867 (2003)
  4. "A biological stagingmodel for operable non-small cell lung cancer", 56, pp.561~566 (2001)
  5. "Abiologic risk model for stage I lung cancer immunohistochemicalanalysis of 408 patients with the use of ten molecular markers", 117, pp.736~743 (1999)
  6. "Localization of matrix metalloproteinase 9 tothe cell surface provides a mechanism for CD44-mediated tumorinvasion", 13, pp.35~48 (1999)
  7. "Splicing choice from tenvariant exons establishes CD44 variability", pp.1225~9
  8. "A new variant of glycopro-teinCD44 confers metastatic potential to rat carcinoma cells", pp.13~24
  9. "CD44 variant isoforms innon-Hodgkin s lymphoma: a new independent prognostic factor", 85, pp.2885~2889 (1995)
  10. "CD44 variant exon epitopes in primary breast cancer and length-of survival", 345, pp.612~619 (1995)
  11. "De novo expression of CD44and survival in gastric cancer", pp.1019~1022 (1993)
  12. "Colorectal cancer prognosisand expression of exon-v6-containing CD44 proteins", pp.1470~1472 (1994)
  13. "Expression of CD44 in humanlung tumors", pen(mb), pp.1381~7
  14. "Expression ofalternatively spliced forms of the CD44 extracellular-matrix receptoron human lung carcinomas", pp.110~5
  15. "Expression of CD44variant exon 6 in stage I non-small cell lung carcinoma as a prognos-tic factor", 58, pp.1108~1110 (1998)
  16. "Histolog-ical typing of lung and pleural tumors WorldHealth Organization International Histological Classification of Tu-mors Histological Typing of Lung and Pleural TumorsHistological Typing of Lung and Pleural Tumors. 3rd ed.", pp.21~66 (1999), Springer-Verlag
  17. "Expression of c-Met andheparan-sulfate proteoglycan forms of CD44 in colorectal cancer", 157, pp.1563~1573 (2000)
  18. "The study of proliferating cellnuclear antigen in colorectal carcinoma", 29, pp.311~320 (1995)
  19. "Tumor angiogenesisand metastasis-correlation in invasive breast carcinoma", 324, pp.1~8 (1991)
  20. "CD44 and cancer screening", 342, pp.548~549 (1993)
  21. "Hyaluronate can func-tion as a cell adhesion molecule and CD44 participates in hyaluronaterecognition", 172, pp.69~75 (1990)
  22. "Expression of CD44standard form and variant isoforms in non-small cell lung carcino-mas", 28, pp.809~814 (1997)
  23. "Natural history of carcinoma of the lung", pp.~96, Mc Graw-Hill
  24. "CD44 splice variants confermetastatic behavior in rats", pp.5292~7, homologous sequences are expressedin human tumor cell lines
  25. "Expression of pro-liferating cell nuclear antigen and CD44 variant isoforms in the pri-mary and metastatic sites of nonsmall cell lung carcinoma with intra-pulmonary metastases", 86, pp.1174~1181 (1999)
  26. "Influence of E-cadherin dys-function upon local invasion and metastasis in non-small cell lungcancer", pp.85~95 (1998)
  27. "Vascular endothelialgrowth factor (VEGF)--mediated angiogenesis is associated withen-hanced endothelial cell survival and induction of Bcl-2 expression", 154, pp.375~384 (1999)
  28. "Angiogenesis as a pre-dictor of survival after surgical resection for stage I non-small-celllung cancer", 115, pp.652~658 (1998)
  29. "Differential expression of hypoxiainducible factor-1 and tumor cell proliferation between squamous cellcarcinomas and adenocarcinomas among operable non-small celllung carcinomas", 18, pp.196~203 (2003)
  30. "Multiple variants of the human lymphocytehoming receptor CD44 generated by insertions at a singlesite in the extracellular domain", pp.4732~9

관련 논문AI추천

이 간행물의 다른 논문 (11건)